MAPT and Alzheimer disease: Our study is in agreement with the previous reports on SHIP2 transcript upregulation in correlation with cognitive deficits and AD lesions in AD and aged brains [65] and on the potential role of SHIP2 as a link of Aβ neurotoxicity to tau pathology in AD [48].